SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

06 Feb 2025 Evaluate
The total revenue for the quarter ended December 2024 remained nearly unchanged at Rs. 4032.55 millions.A big decline of -35.55% was reported for the quarter ended December 2024 to Rs. 226.87  millions from Rs. 352.02 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 364.52 millions from 547.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4032.55 3946.33 2.18 11725.98 11449.94 2.41 15375.94 13388.83 14.84
Other Income 48.74 36.58 33.24 125.77 85.80 46.59 125.66 57.59 118.20
PBIDT 364.52 547.74 -33.45 1358.30 1142.60 18.88 1743.84 830.29 110.03
Interest 12.66 20.44 -38.06 33.60 27.82 20.78 35.09 19.81 77.13
PBDT 351.86 527.30 -33.27 1324.70 1114.78 18.83 1708.75 810.48 110.83
Depreciation 48.08 55.08 -12.71 121.88 152.11 -19.87 219.00 180.06 21.63
PBT 303.78 472.22 -35.67 1202.82 962.67 24.95 1489.75 630.42 136.31
TAX 76.91 120.20 -36.01 306.17 252.92 21.05 380.40 167.99 126.44
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.36 2.03 -314.78
PAT 226.87 352.02 -35.55 896.65 709.75 26.33 1109.35 462.43 139.90
Equity 1095.84 1022.27 7.20 1095.84 1022.27 7.20 1022.27 1022.27 0.00
PBIDTM(%) 9.04 13.88 -34.87 11.58 9.98 16.08 11.34 6.20 82.88

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×